Psoriasiform lesions linked to anti-TNF treatment

VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...

Field of Interest: Dermatology
Type: News Item

Psoriasiform lesions linked to anti-TNF treatment

VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...

Field of Interest: Gastroentero...
Type: News Item

Laparoscopic splenectomy underutilized in the U.S.

LAS VEGAS – Laparoscopic splenectomy has become the preferred surgical approach in the literature, but the number of such procedures performed in the United States remains relatively low, according...

Field of Interest: Gastroentero...
Type: News Item

FDA approves hepatitis C combination pill

The first combination pill to treat chronic hepatitis C virus genotype 1 infection was approved by the Food and Drug Administration Oct. 10. The once-daily tablet under the trade name Harvoni...

Field of Interest: Gastroentero...
Type: News Item

VIDEO: New drug shows efficacy in metastatic CRC

MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.